azacitidine and Autosomal Dominant Cerebellar Ataxia, Type II

azacitidine has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y; Chua, B; Feng, Y; Stuart, C; Wang, J; Yan, H; Yin, D; Zhao, J1

Other Studies

1 other study(ies) available for azacitidine and Autosomal Dominant Cerebellar Ataxia, Type II

ArticleYear
β-arrestin2/miR-155/GSK3β regulates transition of 5'-azacytizine-induced Sca-1-positive cells to cardiomyocytes.
    Journal of cellular and molecular medicine, 2014, Volume: 18, Issue:8

    Topics: Animals; Antimetabolites, Antineoplastic; Arrestins; Azacitidine; beta-Arrestins; Cell Differentiation; Cell Proliferation; Cells, Cultured; Fluorescent Antibody Technique; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Myocardial Reperfusion Injury; Myocytes, Cardiac; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spinocerebellar Ataxias

2014